First Trust Advisors
AMED

First Trust Advisors’s Amedisys AMED Stock Holding History

First Trust Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,572
Closed -$253K – 2573
2025
Q2 		$253K Buy
2,572
+285
+12% +$27K ﹤0.01% 2463
2025
Q1 		$212K Sell
2,287
-97,491
-98% -$8.99M ﹤0.01% 2451
2024
Q4 		$9.06M Buy
+99,778
New +$9.16M 0.01% 1092
2023
Q4 		– Sell
-125,359
Closed -$11.7M – 2341
2023
Q3 		$11.7M Sell
125,359
-141,841
-53% -$13.1M 0.01% 940
2023
Q2 		$24.4M Buy
267,200
+5,100
+2% +$418K 0.03% 663
2023
Q1 		$19.3M Buy
262,100
+198,296
+311% +$17.2M 0.02% 750
2022
Q4 		$5.33M Sell
63,804
-118,735
-65% -$10.7M 0.01% 1156
2022
Q3 		$17.7M Buy
182,539
+64,019
+54% +$7.63M 0.02% 733
2022
Q2 		$12.5M Sell
118,520
-22,343
-16% -$2.85M 0.02% 874
2022
Q1 		$24.3M Sell
140,863
-10,777
-7% -$1.61M 0.02% 735
2021
Q4 		$24.5M Buy
151,640
+106,453
+236% +$17.1M 0.02% 760
2021
Q3 		$6.74M Buy
45,187
+22,284
+97% +$4.63M 0.01% 1145
2021
Q2 		$5.61M Sell
22,903
-69,105
-75% -$18.1M 0.01% 1279
2021
Q1 		$24.4M Sell
92,008
-13,030
-12% -$3.67M 0.03% 642
2020
Q4 		$30.8M Buy
105,038
+12,603
+14% +$3.23M 0.04% 510
2020
Q3 		$21.9M Buy
92,435
+72,089
+354% +$16.4M 0.04% 514
2020
Q2 		$4.04M Sell
20,346
-13,348
-40% -$2.49M 0.01% 1066
2020
Q1 		$6.18M Sell
33,694
-1,681
-5% -$299K 0.01% 799
2019
Q4 		$5.91M Buy
35,375
+11,623
+49% +$1.73M 0.01% 1030
2019
Q3 		$3.11M Sell
23,752
-6,964
-23% -$907K 0.01% 1285
2019
Q2 		$3.73M Sell
30,716
-9,340
-23% -$1.11M 0.01% 1226
2019
Q1 		$4.94M Sell
40,056
-4,932
-11% -$619K 0.01% 1027
2018
Q4 		$5.27M Sell
44,988
-26,194
-37% -$3.09M 0.01% 954
2018
Q3 		$8.89M Buy
71,182
+19,680
+38% +$2.17M 0.02% 870
2018
Q2 		$4.4M Buy
51,502
+36,161
+236% +$2.66M 0.01% 1161
2018
Q1 		$926K Buy
15,341
+1,046
+7% +$59.6K ﹤0.01% 1814
2017
Q4 		$753K Sell
14,295
-24,286
-63% -$1.28M ﹤0.01% 1949
2017
Q3 		$2.16M Buy
38,581
+11,730
+44% +$620K 0.01% 1413
2017
Q2 		$1.69M Buy
26,851
+15,413
+135% +$898K ﹤0.01% 1602
2017
Q1 		$584K Sell
11,438
-499
-4% -$23.8K ﹤0.01% 2024
2016
Q4 		$509K Sell
11,937
-23,682
-66% -$1.01M ﹤0.01% 2118
2016
Q3 		$1.69M Sell
35,619
-9,102
-20% -$454K 0.01% 1428
2016
Q2 		$2.26M Buy
44,721
+12,227
+38% +$617K 0.01% 1250
2016
Q1 		$1.57M Sell
32,494
-28,737
-47% -$1.11M 0.01% 1436
2015
Q4 		$2.41M Sell
61,231
-22,831
-27% -$913K 0.01% 1291
2015
Q3 		$3.19M Buy
84,062
+32,089
+62% +$1.35M 0.01% 1152
2015
Q2 		$2.06M Sell
51,973
-49,444
-49% -$1.54M 0.01% 1514
2015
Q1 		$2.72M Buy
+101,417
New +$2.86M 0.01% 1322
2014
Q3 		– Sell
-19,323
Closed -$323K – 2221
2014
Q2 		$323K Sell
19,323
-8,116
-30% -$115K ﹤0.01% 2037
2014
Q1 		$409K Sell
27,439
-2,823
-9% -$43.4K ﹤0.01% 2000
2013
Q4 		$443K Sell
30,262
-17,232
-36% -$277K ﹤0.01% 1948
2013
Q3 		$817K Sell
47,494
-64,193
-57% -$952K ﹤0.01% 1648
2013
Q2 		$1.3M Buy
+111,687
New +$1.28M 0.01% 1330

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Advisors's AMED Position: Q3 2025 in Review

First Trust Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,572 shares — an estimated $253K sold.

First Trust Advisors first reported a position in AMED in Q2 2013 and held it in 43 quarters. The position peaked at $30.8M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • First Trust Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • First Trust Advisors sold 2,572 Amedisys shares in Q3 2025, an estimated $253K.
  • First Trust Advisors first reported a position in Amedisys in Q2 2013 and held it in 43 quarters.
  • First Trust Advisors's Amedisys position peaked at $30.8M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on First Trust Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.